
Aurora: Bullish On European Opportunity, Improving Financial Profile (NASDAQ:ACB)
24K-Production Thesis Aurora Cannabis’ (NASDAQ:ACB) strategy of prioritizing its global medical-cannabis business while pursuing the premium-priced Canadian consumer market makes sense to cull its operating deficit, I believe, given that medical markets offer stable growth […]